Legal Opinion
Allergan, Inc. v. Sandoz Inc.
Court of Appeals for the Federal Circuit
Decided August 4, 2015No. 2014-1275PublishedCited by 39 opinions
1Opinion of the Court
LOURIE, Circuit Judge.
Sandoz Inc. (“Sandoz”), Lupin Ltd. and Lupin Pharmaceuticals, Inc. (collectively, “Lupin”), and Hi-Tech Pharmacal Co., Inc. (“Hi-Tech”) (collectively, “the Appellants”) 1 appeal from the decision of the United States District Court for the Eastern District of Texas, following a bench trial, which held that the claims of U.S. Patents 7,851,504 (the “'504 patent”), 8,278,353 (the “'353 patent”), 8,299,118 (the “'118 patent”), 8,309,605 (the “'605 patent”), and 8,338,479 (the “'479 patent”), asserted by Allergan, Inc. (“Allergan”), were not shown to be invalid for…
2Cases cited27 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
22 more not listed; retrieve them via the Exa API.
3Cited by39 opinions
- Arctic Cat Inc. v. Bombardier Recreational Products Inc.Court of Appeals for the Federal Circuit · 2017
- E.I. Dupont De Nemours & Co. v. Synvina C.V.Court of Appeals for the Federal Circuit · 2018
- Intendis Gmbh v. Glenmark Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2016
- Nuvo Pharm. (Ireland) Designated Activity Co. v. Dr. Reddy's Labs. Inc.Court of Appeals for the Federal Circuit · 2019
- Adapt Pharma Operations v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2022
34 more not listed; retrieve them via the Exa API.